Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 28, 2025Open Access

Potential Role of GLP-1 Receptor Agonists for the Treatment of Alzheimer's Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

TOTyler OyangSaratoga Hospital

Discussion

Loading...

Member takes

Implication

This review highlights GLP-1 receptor agonists' effects on amyloid burden and neuroinflammation in Alzheimer's disease.

Key Points

  • GLP-1 receptor agonists show potential cognitive benefits in Alzheimer's disease patients, suggesting new treatment avenues.
  • Preclinical studies reveal that GLP-1 receptor agonists can reduce amyloid burden and improve neuronal survival.
  • Research reveals a significant role of GLP-1 receptor signaling in mitigating neuroinflammation associated with Alzheimer's.
  • Emerging therapeutic strategies like dual agonist treatments may accelerate the development of GLP-1 receptor agonists for Alzheimer's.

Cite This Study

Tyler Oyang (2025) studied this question.

synapsesocial.com/papers/68d90a0f41e1c178a14f6a7dhttps://doi.org/10.58445/rars.3139
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1GLP-1 and the Degenerating Brain: Exploring Mechanistic Insights and Therapeutic Potential2025 · 29 citations
  2. 2The Role of Glucagon-like Peptide-1 Receptor Agonists in Alzheimer’s and Parkinson’s Disease: A Literature Review of Clinical Trials2025
  3. 3A New Alzheimers Disease Interventive Strategy: GLP-12004 · 115 citations
  4. 4Glucagon-Like Peptide-1 Receptor Agonists in Neurodegenerative Diseases: A Comprehensive Review2025 · 5 citations
  5. 5The promise of GLP-1 receptor agonists for neurodegenerative diseases2026 · 22 citations